Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Vote In favor of Your Number one Sort Of Blossoms - 2Father and son spending Christmas together after health scares
- 3Reporter's Notebook: The Post embeds with foreign armies visiting the IDF
- 4Thyssenkrupp to suspend electrical steel production at French site
- 5Artemis II live updates: NASA's moon mission breaks Apollo record for farthest distance humans have traveled from Earth
- the Kinds of Thailand: Decision in favor of Your Number one Thai Dish!
- Free Fuel Giveaway Sparks Traffic Mayhem Before Police Shut It Down
- The gay hockey show no one saw coming — and everyone is suddenly obsessed with
- My Excursion to a Better Way of life: Health Experiences
- Former school bus aide pleads guilty to assaulting 3 autistic students in Colorado
- 2025 Arctic League telethon raises more than $39k
- Step by step instructions to Pick an Incineration Urn: Variables to Consider
- Make Your Fantasy Closet: 10 Immortal Design Fundamentals
- 25 Most Beautiful Villages in France You Can Actually Visit
